Client Ramius Launches Hostile Tender Offer for Cypress Bioscience

Firm News

Olshan’s client Ramius LLC announced that it commenced a tender offer to acquire all of the outstanding shares of common stock of drugmaker Cypress Bioscience, Inc. after the Cypress board rejected an earlier offer to negotiate an acquisition of Cypress. Many national media outlets, including The New York Times, The Wall Street Journal MarketWatch and Law 360(subscription required) have reported on the story.

Steve Wolosky, Andrew M. Freedman and Jason W. Soncini comprise the Olshan team representing Ramius.

Media Contact

Marketing Contact
Mizi Mehaj
Marketing & Administrative Manager

Jump to Page

Necessary Cookies

Necessary cookies enable core functionality such as security, network management, and accessibility. You may disable these by changing your browser settings, but this may affect how the website functions.

Analytical Cookies

Analytical cookies help us improve our website by collecting and reporting information on its usage. We access and process information from these cookies at an aggregate level.